gemcitabine has been researched along with Cutaneous T-Cell Lymphoma in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (47.37) | 29.6817 |
2010's | 8 (42.11) | 24.3611 |
2020's | 2 (10.53) | 2.80 |
Authors | Studies |
---|---|
Assaf, C; Blazejak, C; Gambichler, T; Gosman, J; Klemke, CD; Nicolay, JP; Olk, J; Stadler, R; Stendel, S; Stranzenbach, R; Wehkamp, U; Weyermann, M; Wobser, M | 1 |
Bianchi, L; Cantonetti, M; Di Raimondo, C; Meconi, F; Monopoli, A; Narducci, MG; Nunzi, A; Rapisarda, V; Scala, E; Tesei, C; Vaccarini, S; Zizzari, A | 1 |
Cronin, M; Fox, JD; Gonzalez, AM; Kirsner, RS; Mackrides, N; Nichols, AJ; Zito, PM | 1 |
Chan, C; Counsell, N; Cowan, R; Gilson, D; Illidge, T; Morris, S; Patrick, P; Popova, B; Scarisbrick, J; Smith, P; Whittaker, S | 1 |
Argnani, L; Casadei, B; Maglie, R; Pellegrini, C; Stefoni, V; Zinzani, PL | 1 |
Affandi, AM; Blumetti, TP; Fernandez-PeƱas, P; Hertzberg, M; Wells, J | 1 |
Amoh, Y; Masuzawa, M; Takasu, H | 1 |
Chen, CC; Teng, CL; Yeh, SP | 1 |
Bachelez, H; Beylot-Barry, M; Chaoui, D; Dubertret, L; Ingen-Housz-Oro, S; Jidar, K; Morel, P; Paul, C; Sigal-Grinberg, M | 1 |
Balaraman, B; Conley, JA; Sheinbein, DM | 1 |
Battistella, M; Sassolas, B | 1 |
Bianchi, L; Cantonetti, M; Chimenti, S; Fargnoli, MC; Muscardin, LM; Orlandi, A; Pagnanelli, G | 1 |
Dumontet, C | 1 |
Besalduch, J; Galmes, B; Gines, J; Gutierrez, A; Ramos, R; Rodriguez, J; Sampol, A | 1 |
Alinari, L; Baccarani, M; Bernengo, MG; Berti, E; Marchi, E; Pagano, L; Pileri, S; Pimpinelli, N; Rupoli, S; Stefoni, V; Tani, M; Zaja, F; Zinzani, PL | 1 |
Apisarnthanarax, N; David, CL; Duvic, M; Kurzrock, R; Talpur, R; Wen, S | 1 |
Ascani, S; Baliva, G; Bendandi, M; Gherlinzoni, F; Magagnoli, M; Modugno, G; Orcioni, GF; Pileri, SA; Simoni, R; Tura, S; Zinzani, PL | 1 |
Nguyen, NP; Sallah, S; Wan, JY | 1 |
Gandhi, V; Krett, N; Nabhan, C; Rosen, S | 1 |
5 review(s) available for gemcitabine and Cutaneous T-Cell Lymphoma
Article | Year |
---|---|
[Gemcitabine Monotherapy for Advanced Mycosis Fungoides--Two Case Reports and a Literature Review].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Mycosis Fungoides; Prednisone; Skin Neoplasms; Vincristine | 2015 |
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclosporine; Cytarabine; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Multimodal Imaging; Panniculitis; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Skin Neoplasms; Subcutaneous Fat; Tomography, X-Ray Computed | 2016 |
Evaluation of cutaneous angioimmunoblastic T-cell lymphoma.
Topics: Aged; Arthralgia; Cyclophosphamide; Deoxycytidine; Diphtheria Toxin; Doxorubicin; Epstein-Barr Virus Infections; Gemcitabine; Gene Rearrangement, T-Lymphocyte; Humans; Immunoblastic Lymphadenopathy; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Prednisolone; Pruritus; Recombinant Fusion Proteins; Retrospective Studies; Skin Neoplasms; Stem Cell Transplantation; Vinblastine; Vincristine; Vinorelbine | 2011 |
[The role of gemcitabine in hematology].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; DNA Damage; DNA, Neoplasm; Drug Design; Gemcitabine; Hematologic Neoplasms; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Multiple Myeloma; Neoplasm Proteins; Nucleotides; Ribonucleotide Reductases; Salvage Therapy; Treatment Outcome | 2002 |
Gemcitabine in hematologic malignancies.
Topics: Antimetabolites, Antineoplastic; Clinical Trials as Topic; Deoxycytidine; DNA; Gemcitabine; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Tumor Cells, Cultured | 2001 |
5 trial(s) available for gemcitabine and Cutaneous T-Cell Lymphoma
Article | Year |
---|---|
Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Remission Induction; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome; United Kingdom | 2013 |
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Treatment Outcome | 2005 |
Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Receptors, Interleukin-2; Sezary Syndrome; Skin Neoplasms; Treatment Outcome | 2006 |
Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Skin Neoplasms; Survival Rate | 2000 |
Treatment of refractory T-cell malignancies using gemcitabine.
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Leukemia, Prolymphocytic; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Recurrence; Salvage Therapy; Treatment Outcome | 2001 |
9 other study(ies) available for gemcitabine and Cutaneous T-Cell Lymphoma
Article | Year |
---|---|
Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network.
Topics: Breast Neoplasms; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2022 |
Continuous low-dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study.
Topics: Deoxycytidine; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Retrospective Studies; Sezary Syndrome; Skin Neoplasms | 2022 |
Widespread Skin Necrosis Secondary to Gemcitabine Therapy.
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Diagnosis, Differential; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Middle Aged; Skin Neoplasms; Stevens-Johnson Syndrome | 2018 |
Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome | 2014 |
Gemcitabine and vinorelbine treatment in cutaneous T-cell lymphoma in four patients.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Retreatment; Skin Neoplasms; Treatment Outcome; Vinblastine; Vinorelbine | 2015 |
Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Vinblastine; Vinorelbine | 2009 |
[Therapeutic perspectives of cutaneous T-cell lymphoma].
Topics: Antineoplastic Agents; Bexarotene; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Histone Deacetylase Inhibitors; Humans; Interferons; Lymphoma, T-Cell, Cutaneous; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes | 2011 |
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; CD4 Antigens; CD8 Antigens; Deoxycytidine; Gemcitabine; Humans; Lymphatic Diseases; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms | 2002 |
Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD8 Antigens; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Immunophenotyping; Lymphoma, T-Cell, Cutaneous; Organoplatinum Compounds; Oxaliplatin; Pentostatin; Prednisone; Remission Induction; Salvage Therapy; Skin Neoplasms; Vincristine | 2004 |